Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

New medicines: human

Get the latest updates from New medicines: human directly as they happen.

Follow now 506 followers

Latest posts

Last updated 9 days ago

Human medicines European public assessment report (EPAR): Wayrilz, rilzabrutinib, Status: Opinion

9 days ago

Human medicines European public assessment report (EPAR): Wayrilz, rilzabrutinib, Status: Opinion

Human medicines European public assessment report (EPAR): Rezurock, Belumosudil, Status: Opinion

9 days ago

Human medicines European public assessment report (EPAR): Rezurock, Belumosudil, Status: Opinion

Human medicines European public assessment report (EPAR): Brinsupri, Brensocatib, Status: Opinion

9 days ago

Human medicines European public assessment report (EPAR): Brinsupri, Brensocatib, Status: Opinion

Human medicines European public assessment report (EPAR): Enflonsia, clesrovimab, Status: Opinion

about 1 month ago

Human medicines European public assessment report (EPAR): Enflonsia, clesrovimab, Status: Opinion

Human medicines European public assessment report (EPAR): Imaavy, nipocalimab, Status: Opinion

about 1 month ago

Human medicines European public assessment report (EPAR): Imaavy, nipocalimab, Status: Opinion

Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Status: Opinion

about 1 month ago

Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Status: Opinion

Human medicines European public assessment report (EPAR): Degevma, denosumab, Status: Opinion

about 1 month ago

Human medicines European public assessment report (EPAR): Degevma, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR): Kefdensis, denosumab, Status: Opinion

about 1 month ago

Human medicines European public assessment report (EPAR): Kefdensis, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR): Usgena, ustekinumab, Status: Opinion

about 1 month ago

Human medicines European public assessment report (EPAR): Usgena, ustekinumab, Status: Opinion

Human medicines European public assessment report (EPAR): Acvybra, denosumab, Status: Opinion

about 1 month ago

Human medicines European public assessment report (EPAR): Acvybra, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR): Denosumab Intas, denosumab, Status: Opinion

about 1 month ago

Human medicines European public assessment report (EPAR): Denosumab Intas, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR): Gobivaz, golimumab, Status: Opinion

about 1 month ago

Human medicines European public assessment report (EPAR): Gobivaz, golimumab, Status: Opinion